Dale L Greiner Selected Research

4 Insulin-Dependent Diabetes Mellitus

4/2007	Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene.
4/2005	The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.
11/2002	The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dale L Greiner Research Topics

Disease

28	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 11/2002
18	Neoplasms (Cancer) 11/2020 - 01/2008
17	Infections 02/2020 - 06/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2005
6	Foreign Bodies (Foreign Body) 07/2021 - 06/2015
6	Fibrosis (Cirrhosis) 01/2021 - 06/2015
4	Hyperglycemia 01/2021 - 03/2008
4	Virus Diseases (Viral Diseases) 11/2010 - 06/2002
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 02/2014
3	Leukemia 01/2021 - 02/2014
3	Inflammation (Inflammations) 11/2017 - 01/2008
3	Breast Neoplasms (Breast Cancer) 01/2015 - 04/2013
3	4 Insulin-Dependent Diabetes Mellitus 04/2007 - 11/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 04/2014
2	Hypersensitivity (Allergy) 01/2020 - 01/2016
2	Anaphylaxis (Anaphylactic Shock) 01/2019 - 01/2016
2	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 07/2010
2	Wounds and Injuries (Trauma) 11/2017 - 04/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2016 - 07/2010
2	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 07/2012
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2016 - 10/2009
2	Insulin Resistance 03/2016 - 01/2016
2	Communicable Diseases (Infectious Diseases) 08/2013 - 05/2008
2	Body Weight (Weight, Body) 03/2011 - 05/2004
1	Cytokine Release Syndrome 01/2020
1	Diabetes Mellitus 01/2020
1	Fever (Fevers) 01/2020
1	Immune System Diseases (Immune Disorders) 01/2019
1	Foreign-Body Reaction 11/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Lymphoma (Lymphomas) 01/2017

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 01/2022 - 08/2003
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2004
5	CytokinesIBA 02/2020 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2010
4	AntigensIBA 01/2022 - 10/2009
4	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2008
4	Phosphotransferases (Kinase)IBA 07/2012 - 05/2005
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2013
3	HydrogelsIBA 01/2016 - 06/2015
3	IntegrinsIBA 01/2015 - 04/2013
3	LigandsIBA 01/2015 - 03/2009
3	Poly I-CIBA 04/2007 - 11/2002
2	Biocompatible Materials (Biomaterials)IBA 07/2021 - 01/2017
2	Monoclonal AntibodiesIBA 01/2020 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 07/2010
2	C-PeptideIBA 01/2018 - 03/2008
2	Interleukin-2 (IL2)IBA 03/2016 - 10/2009
2	Streptozocin (Streptozotocin)FDA Link 03/2016 - 03/2011
2	EnzymesIBA 01/2016 - 11/2010
2	AntibodiesIBA 01/2015 - 10/2009
2	Immunoglobulin M (IgM)IBA 01/2015 - 10/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 09/2011
2	VaccinesIBA 07/2012 - 09/2008
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2012 - 10/2009
2	RNA (Ribonucleic Acid)IBA 09/2011 - 10/2009
2	Protein Isoforms (Isoforms)IBA 03/2011 - 05/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 01/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2008 - 01/2004
2	Toll-Like Receptor AgonistsIBA 01/2007 - 01/2005
1	Dinoprostone (PGE2)FDA Link 01/2021
1	ProstaglandinsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2020
1	Granzymes (Granzyme)IBA 11/2020
1	NF-kappa B (NF-kB)IBA 02/2020
1	Viral ProteinsIBA 02/2020
1	Interferon Type IIBA 02/2020
1	SodiumIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	PolymersIBA 01/2020
1	AK002IBA 01/2019
1	triphosphoric acid (triphosphate)IBA 01/2019
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	pembrolizumabIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Glucagon (Glukagon)FDA Link 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Complement System Proteins (Complement)IBA 01/2017

Therapy/Procedure

18	Therapeutics 11/2020 - 04/2007
9	Transplantation 01/2021 - 06/2002
5	Islets of Langerhans Transplantation 01/2021 - 07/2003
4	Immunotherapy 11/2020 - 04/2011
2	Drug Therapy (Chemotherapy) 01/2015 - 02/2014
1	Electrodes (Electrode) 01/2019
1	Precision Medicine 01/2019
1	Microspheres (Microsphere) 11/2018